Table 1 Clinical characteristics of patients at the time of study admission (day 1 of intensive care unit stay) for the entire cohort and for the two sub-groups “sepsis” and “no-sepsis”
Variable | Modality/statistics | Total (N = 243) | No Sepsis (N = 190) | Sepsis (N = 53) | p value |
|---|---|---|---|---|---|
Gender | F | 90/243 (37%) | 77/190 (41%) | 13/53 (25%) | 0.0331 |
M | 153/243 (63%) | 113/190 (59%) | 40/53 (75%) | ||
Age | Median (Q1;Q3) | 65.0 (54.0;73.0) | 65 (54;72) | 64 (55;73) | 0.9152 |
SOFA score | Median (Q1;Q3) | 6 (5;9) | 6 (4;9) | 7 (5;9) | 0.0402 |
Charlson score | 0 | 51/243 (21%) | 46/190 (24%) | 5/53 (9%) | 0.0551 |
1–2 | 84/243 (35%) | 60/190 (32%) | 24/53 (45%) | ||
3–4 | 47/243 (19%) | 34/190 (18%) | 13/53 (25%) | ||
5 and more | 52/243 (21%) | 42/190 (22%) | 10/53 (19%) | ||
Non-reported Charlson score | 9/243 (4%) | 8/190 (4%) | 1/53 (2%) | ||
Reason for ICU admission | CNS (trauma, stroke, haemorrhage) | 94/243 (39%) | 74/190 (39%) | 20/53 (38%) | 0.6573 |
Cardiovascular | 76/243 (31%) | 60/190 (32%) | 16/53 (30%) | ||
Abdominal/digestive | 45/243 (19%) | 32/190 (17%) | 13/53 (25%) | ||
Respiratory | 18/243 (7%) | 16/190 (8%) | 2/53 (4%) | ||
Metabolic | 9/243 (4%) | 7/190 (4%) | 2/53 (4%) | ||
ICU treatments | Mechanical ventilation | 187/243 (77%) | 143/190 (75%) | 44/53 (83%) | 0.2361 |
Vasopressors | 95/243 (39%) | 69/190 (36%) | 26/53 (49%) | 0.1751 | |
No-reported vasopressors | 16/243 (7%) | 15/190 (8%) | 1/53 (2%) | ||
Comorbidities | Cancer | 40/243 (16%) | 33/190 (17%) | 7/53 (13%) | 0.4301 |
Heart disease | 35/243 (14%) | 26/190 (14%) | 9/53 (17%) | 0.5901 | |
Pulmonary disease | 31/243 (13%) | 26/190 (14%) | 5/53 (9%) | 0.3811 | |
Renal disease | 29/243 (12%) | 23/190 (12%) | 6/53 (11%) | 0.8321 | |
Liver disease | 17/243 (7%) | 12/190 (6%) | 5/53 (9%) | 0.5433 | |
ICU length of stay | Median (Q1;Q3) | 9 (6;17) | 7 (5;13) | 21 (14;27) | < 0.0012 |